Skip to main content
Quest Diagnostics

NGS Panels for Hereditary Hearing Loss Testing With Approaches for Difficult-to-Screen Regions

CAGC 2021: Canadian Association of Genetic Counsellors
Virtual Meeting, Sep 29-Oct 2, 2021

Next-generation sequencing panels for hereditary hearing loss testing with approaches for difficult-to-sequence regions

Authors: Gall K, Tuupanen S, Sarantaus L, Gandia M, Duzkale H, Saarinen I, Sistonen J, Koskenvuo J, Alastalo T-P

Specialties: genetics, neurology

Disclaimer: One or more of the authors of this publication were employed at the time by BluePrint Genetics, a subsidiary of Quest Diagnostics.

Our company

Quest® is the brand name used for services offered by Quest Diagnostics Incorporated and its affiliated companies. Quest Diagnostics Incorporated and certain affiliates are CLIA-certified laboratories that provide HIPAA-covered services.  Other affiliates operated under the Quest® brand, such as Quest Consumer Inc., do not provide HIPAA-covered services. 

 

Quest®, Quest Diagnostics®, any associated logos, and all associated Quest Diagnostics registered or unregistered trademarks are the property of Quest Diagnostics. All third-party marks—® and ™—are the property of their respective owners. © 2025 Quest Diagnostics Incorporated. All rights reserved. Image content features models and is intended for illustrative purposes only.